Tags: Trade

SOCMA Engages USTR on 301 Tariffs

SOCMA recently submitted a formal letter to United States Trade Representative (USTR), Ambassador Katherine Tai, requesting a meeting on the 301 China Tariffs. The purpose of the meeting is not only to urge USTR to reopen the exclusion process for chemicals imported from China, but to educate and inform USTR on the concerns and impacts of the tariffs on the specialty chemicals industry.

February 14, 2022

SOCMA Launches Policy Webinar Series in April

As the specialty chemicals industry anticipates new policy and regulations coming under the Biden Administration, the Society of Chemical Manufacturers & Affiliates (SOCMA) is hosting its Policy Webinar Series throughout April to focus these key topics that are crucial to its membership and the value chain.

March 30, 2021

SOCMA Seeks Member Input on Chinese-origin Medical-Care Products

The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.

March 31, 2020